The master of arts degree in Human Dimensions of Organizations is for mid-career professionals who are interested in learning about the application of the humanities and social/behavioral sciences to their work lives. We work with full and associate faculty to teach a variety of courses. Faculty are paid an overload for teaching in this program. UT staff are welcome additions to our cohort.

The Kendra Scott Women’s Entrepreneurial Leadership Institute (KS WELI) supports creatives, founders, leaders, and allies by redefining leadership and entrepreneurship. KS WELI equips and empowers students of all backgrounds through engaging programming and events, spotlighting women-led businesses through the FoundHER Program, and sponsoring interdisciplinary courses within the McCombs Entrepreneurship Minor. Since its founding, KS WELI has become a force on UT’s campus to grow and support the number of women-owned and women-led businesses.

The Moffett Family Summer Entrepreneurship Academy (SEA) is an in-person, 8-week summer program for UT Austin undergraduates. SEA participants will complete 4 of 5 required courses for the Entrepreneurship Minor. Students will develop a foundational understanding of entrepreneurship, through terminology, case-based learning, key theories, and empirical-based practices, while working with local startups, corporate sponsors, McCombs alumni, and entrepreneurial mentors.

For companies that have participated in our proposal preparation workshops and on-demand webinars, select 1:1 proposal preparation support may be available. Inquiries may be sent to Andrew Worden, Entrepreneurship Program Manager at Andrew.worden@austin.utexas.edu

Get help preparing your SBIR/STTR proposals. For UT Austin-affiliated startups preparing SBIR/STTR Phase I or Phase II proposals. Work with expert proposal preparers and ask questions specific to your proposal. Learn the details of agency-specific proposal preparation including electronic submission and commercialization plans. Agency-specific workshops for the National Science Foundation (NSF), Department of Defense (DOD), and National Institutes of Health (NIH) are offered periodically.

Interested in SBIR/STTR funding but not sure where to begin? Writing your proposal and looking for expert guidance? On-demand webinars about SBIR/STTR programs and agency proposal requirements are available to the UT Austin community at no cost through our collaboration with BBC Entrepreneurial Training & Consulting.

UT Austin's Simulation and Game Applications (SAGA) Lab develops software for funded projects and assists in preparing grant proposals. We create games, interactive/immersive environments, mobile apps, web dashboards, game-simulations, and VR/AR software solutions. The SAGA Lab and partnering UT faculty co-design the software solution, which is developed by paid student-interns. We have a long track record of creating software solutions for research and education spanning nearly 10 years.

A 9-week summer accelerator program that picks the most promising emerging UT startups (undergrad, grad, and faculty teams) and helps them confront their next market-driven milestone. In its 13th year, alumni companies have collectively raised $100M and generated over $400M in valuation.

Texas Biodesign is inspired by Stanford Biodesign’s process of front-end innovation development, in which interdisciplinary teams of researchers, engineers, business participants, and clinicians work to understand how to use needs-driven innovation to solve medical and business problems. Texas Biodesign is a collaboration between UT’s Texas Innovation Center and Texas Venture Labs, UT MD Anderson Cancer Center, and NASA.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.